adjuvant pd-(l)1 inhibitors for melanoma
Published 7 years ago • 124 plays • Length 4:01Download video MP4
Download video MP3
Similar videos
-
8:01
anti–pd-1 adjuvant therapy in melanoma
-
9:18
adjuvant immunotherapy for melanoma
-
5:57
adjuvant ipilimumab in high-risk melanoma
-
5:37
pd-1 inhibitor use in melanoma
-
5:12
emerging adjuvant and neoadjuvant options for melanoma
-
1:02:49
resectable melanoma: immune checkpoint inhibitors as adjuvant and neoadjuvant therapy
-
4:29
anti–pd-1 therapy in metastatic melanoma
-
2:07
efficacy of pd-1/pd-l1 inhibitors in melanoma
-
7:24
molecular testing in melanoma: braf and pd-l1
-
4:14
adjuvant therapy for melanoma: novel treatment options
-
2:40
dr. eggermont on the impact of adjuvant anti–pd-1 agents in melanoma
-
4:49
emerging pd-l1 inhibitors for hnscc
-
8:43
future role of checkpoint inhibitors in melanoma
-
8:47
adjuvant therapy in melanoma: targeted vs immuno-oncology
-
2:35
beyond anti-pd-1 and anti-ctla-4 in melanoma
-
0:55
dr. luke discusses pd-1 plus ido inhibitors in melanoma
-
3:28
treatment duration for pd-1 inhibitors in melanoma
-
7:03
adjuvant therapy for melanoma
-
1:43
dr. moyers on real-world data with adjuvant immunotherapy in melanoma